Djibouti
5 Vaccines Approved for Use in Djibouti
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: dj.usembassy.gov
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: dj.usembassy.gov
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
42 trials in 10 countries
Approval Source: dj.usembassy.gov
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: dj.usembassy.gov